Thyrocare Technologies Limited

THYROCARE

INE594H01019

Healthcare Facilities & Services

Delayed Bombay S.E. Other stock markets 02:46:23 03/06/2024 pm IST			5-day change	1st Jan Change
606.2 ^INR	-1.00%		-2.20%	-5.80%

14/05	Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024
14/05	Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Thyrocare Technologies Limited Proposes Final Dividend for the Financial Year 2023-24

May 14, 2024 at 03:30 pm IST

Thyrocare Technologies Limited proposed final Dividend of INR 18/- per equity share of face value of INR 10/- each for the financial year 2023-24, for approval at the ensuing Annual General Meeting.

Latest news about Thyrocare Technologies Limited

Transcript : Thyrocare Technologies Limited, Q4 2024 Earnings Call, May 14, 2024	14/05
Thyrocare Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	14/05	CI
Thyrocare Technologies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	14/05	CI
Thyrocare Technologies Limited Proposes Final Dividend for the Financial Year 2023-24	14/05	CI
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10/05	RE
Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	16/04	CI
Thyrocare Technologies Completes Acquisition of Think Health; Shares Jump 6%	28/02	MT
Thyrocare Technologies Limited completed the acquisition of Think Health Diagnostic Private Limited.	27/02	CI
Thyrocare Technologies Limited Pays and Settles Due Cess Amount Including Interest and Penalty Amount to Navi Mumbai Municipal Corporation, Cess Department	23/02	CI
Thyrocare Technologies Appoints Chief Commercial Officer	23/02	MT
Thyrocare Technologies Limited Appoints Nitin Chugh as Chief Commercial Officer	23/02	CI
Thyrocare Technologies Posts Gains in Fiscal Q3 Consolidated Profit	02/02	MT
Transcript : Thyrocare Technologies Limited, Q3 2024 Earnings Call, Feb 01, 2024	01/02
Thyrocare Technologies Limited Appoints Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	01/02	CI
Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01/02	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01/02	RE
Thyrocare Technologies to Acquire 100% Stake in Think Health Diagnostic	01/02	MT
Thyrocare Technologies Limited agreed to acquire Think Health Diagnostic Private Limited for INR 3.2 million.	01/02	CI
Transcript : Thyrocare Technologies Limited, Q2 2024 Earnings Call, Oct 31, 2023	31/23/31
Indian shares set to open lower with HDFC, Fed decision in focus	20/23/20	RE
Thyrocare Technologies Forms Joint Venture in Tanzania	20/23/20	MT
Thyrocare Technologies Limited Enter into A Subscription Agreement At Tanzania with Kastipharm Limited and Other Individuals for Setting Up A Joint Venture Company	19/23/19	CI
Thyrocare Technologies Names CFO	02/23/02	MT
Transcript : Thyrocare Technologies Limited, Q1 2024 Earnings Call, Aug 01, 2023	01/23/01
Thyrocare Technologies Limited Appoints Alok Kumar Jagnani as Chief Financial Officer	01/23/01	CI

Chart Thyrocare Technologies Limited

Duration

Period

More charts

Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.

Sector

Healthcare Facilities & Services

Calendar

31/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Thyrocare Technologies Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

612.2 INR

Average target price

740 INR

Spread / Average Target

+20.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
THYROCARE TECHNOLOGIES LIMITED	-5.80%	388M
SONIC HEALTHCARE LIMITED	-24.66%	7.76B
RADNET, INC.	+68.65%	4.33B
SYNLAB AG	-2.80%	2.64B
DR. LAL PATHLABS LIMITED	+3.58%	2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.16B
NEOGENOMICS, INC.	-15.27%	1.75B
FLEURY S.A.	-22.12%	1.46B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.17B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.14B

Medical & Diagnostic Laboratories